Seen that? - Bayer Says: You Eat Too Much

Filed in archive Best of on February 14, 2010

Bayer Says: You Eat Too Much Daily Diabetic

The indomitable Bayer AG company, producers of pills and potions that fight everything from upset tummies to heart disease, has dumped one of its partners today. Last year, Bayer's Alka Seltzer division sponsored the U.S. Open Championship of the International Federation of Competitive eating Inc. group. Although the sponsor may seem apropos considering the indigestion the contestants would no doubt experience, it's hard to miss the irony of a gluttony [...] Read More


Winner of 2007 $100,000 Bayer Dream Fund™ Contest, Announced by Bayer Diabetes Care Daily Diabetic

Wendy Coleman, Ph.D., director of Theater Ensemble and Speech at Albany State University in Georgia - has been announced by the Bayer Diabetes Care as the 2007 winner of the Bayer Dream Fund. Bayer Dream Fund is a contest for people with diabetes who want to achieve a special dream that might not have been possible without control of their diabetes. Through this award, professor Coleman will compose and perform a [...] Read More


Bayer Diabetes Care Launched A1CNow® SELFCHECK For Home Use Daily Diabetic

Bayer Diabetes Care announced the launch of A1CNow®SELFCHECK - a new A1C monitor that enables people with diabetes to check their A1C level at home. As you may know, an A1C reading provides the average blood sugar level over the past three months and indicates how well blood sugar is being managed. With Bayer's A1CNow®SELFCHECK - which was recently cleared by the FDA - patients will be able to more closely [...] Read More


Bayer Buys Biotech Co. Icon Genetics The Biotech Weblog

The chemical company Bayer AG said Wednesday it has acquired Icon genetics AG, a biotech company working on methods for the development and use of engineered plants for producing pharmaceuticals and other high-value compounds. The acquisition will strengthen Bayer's activities aimed at producing specific pharmaceutical substances in plants (plant-made pharmaceuticals, or PMPs). This technology utilizes the natural protein production processes in plants as a way of producing therapeutically active substances. Icon Genetics [...] Read More


Bayer-Schering Pharmaceuticals: A $20B Merger? The Biotech Weblog

Yes, that's right. If Schering accepts the bid, two of Germany's biggest pharmaceutical companies would merge and operate under one name. Bayer AG offered $20.01 billion, equivalent to $104.28 per share, making the other contender, Merck KGaA, abandon the takeover bidding. The impacts of this potential merger? The planned merger of Schering AG and the Bayer pharmaceuticals division will create a new heavyweight of international standing in pharmaceutical specialty products. It is [...] Read More